(PharmaNewsWire.Com, January 03, 2017 ) Cardiac Assist Devices (CAD) are type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain the optimum blood flow throughout the body. Cardiac Assist Devices can be segmented in three types ventricular assist devices, intra-aortic balloon pumps (IABPs) and total artificial heart. Ventricular assist device (VAD) is a mechanical pump which takes blood from a lower chamber of the heart and pumps it to the body and vital organs. Ventricular devices are of two types right ventricular assist device (RVAD), left ventricular assist device (LVAD) and if both the ventricular assist devices are used they’re known as biventricular assist device (BIVAD). Intra-aortic balloon pump is a type of CAD device which increases myocardial oxygen perfusion and cardiac output at the same time. Total artificial heart is a device which replaces the lower chambers of heart and recovers failing heart by performing all functions of a normal heart.
Cardiac assist devices market is expected to be driven by global aging population and increase in cardiovascular diseases. A another factor responsible for market growth of this market is lack of donor hearts for transplantation leading to increase in cardiac assist devices implantations in patients with severe heart complications. In future technological advancements and more efficient and minimally invasive devices are expected to drive the market.
North America is the leading markets for Cardiac Assist Devices (CAD) because of highest heart failure cases diagnosed, technological development, high patient awareness and reimbursement coverage for CAD implantation procedures. Europe is the second largest market following North Amercia with second largest highest prevalence for cardiac diseases and increase in population exceeding 60 - 65 years of age group. Asia Pacific and Rest of the World are the regions including China, India, Brazil, Russia and South Africa has significantly large number of underserved patients suffering with cardiac diseases hence represented as future attractive markets for CAD.
Some of the key players of Cardiac Assist Devices (CAD) market are Berlin Herat GmbH, ABIOMED, Inc., MAQUET GmbH & Co. KG, Thoratec Corporation, Teleflex Incorporated, HeartWare International, Inc. and SynCardia Systems, Inc.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
North America Asia Pacific Europe Rest of the World
For More Information Kindly Contact:
ResearchMoz Mr. Nachiket Ghumare, Tel: +1-518-621-2074 USA-Canada Toll Free: 866-997-4948 Email: email@example.com Follow us on LinkedIn @ http://bit.ly/1TBmnVG
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: